Takeda Pharmaceutical
TAK
#477
Rank
HK$322.24 B
Marketcap
HK$101.64
Share price
-0.15%
Change (1 day)
-7.37%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2024 (TTM): HK$21.63 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are HK$30.56 Billion. In 2023 the company made an earning of HK$17.74 Billion a decrease over its 2022 earnings that were of HK$24.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$21.63 B21.91%
2023 HK$17.74 B-28.11%
2022 HK$24.68 B-41.15%
2021 HK$41.94 B78.15%
2020 HK$23.54 B246.83%
2019 HK$6.78 B-48.74%
2018 HK$13.24 B-23.86%
2017 HK$17.39 B21.77%
2016 HK$14.28 B-253.22%
2015 -HK$9.33 Billion-159.7%
2014 HK$15.61 B12.76%
2013 HK$13.84 B2.7%
2012 HK$13.48 B-57.11%
2011 HK$31.43 B-10.11%
2010 HK$34.97 B-4.2%
2009 HK$36.50 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$142.94 B 562.29%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$57.56 B 166.71%๐Ÿ‡ซ๐Ÿ‡ท France
HK$53.95 B 149.97%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$98.93 B 358.40%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-HK$6.15 Billion-128.46%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.80 B-68.46%๐Ÿ‡ฎ๐Ÿ‡ณ India
HK$36.35 B 68.46%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$32.41 B 50.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$116.35 B 439.09%๐Ÿ‡บ๐Ÿ‡ธ USA